Physician profile
Angela S Wright
NPI 1154454080
$2,676.82
in general payments reported to CMS, 2019-2025
12 companies · $574 in 2025
The $574 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $248 · 2023: $1,108 · 2024: $747 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,883.51 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $183.29 | 2023 | Aptiom |
| Jazz Pharmaceuticals INC. | $135.32 | 2023-2024 | |
| Ucb, INC. | $84.58 | 2022 | |
| Tg Therapeutics, INC. | $80.28 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.35 | 2023 | Gammagard |
| Harmony Biosciences LLC | $71.97 | 2022-2024 | Wakix |
| Acorda Therapeutics, INC | $69.14 | 2022-2023 | Inbrija, Ampyra |
| Amgen INC. | $31.22 | 2024 | Aimovig |
| Biogen, INC. | $29.44 | 2023 | Vumerity, Tysabri |
| Emd Serono, INC. | $18.75 | 2023 | Mavenclad |
| Pfizer INC. | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.